Abstract
MicroRNAs (miRNAs) are short non-coding RNAs known to be involved in the gene regulatory functions in human. Major histocompatibility complex (MHC) located on the short arm of chromosome 6 remains as one of the most important regions associated with several human diseases. The complex spans ~4 Mb and covers >120 expressed genes. Gene expression at transcriptional and post transcriptional level is modulated by microRNA (miRNA) in collision with sequence polymorphism and epigenetic factors. In this study, we aim to predict miRNA responsible for different immunological functions and disorders in MHC region. Sequential and structural features of microRNAs were used for the classification of miRNA and other non-coding RNA data. Support vector machine (SVM) classifier was used for prediction and evaluated by jackknife validation technique. Overall accuracy was found to be 97.56% using leave-one-out cross validation technique. These experimental results confirm that our classification method predicts immune related miRNA with high accuracy.
Keywords: microRNA, leave-one-out cross validation, major histocompatability complex, support vector machine.
Current Bioinformatics
Title:Prediction of miRNA in Human MHC that Encodes Different Immunological Functions Using Support Vector Machines
Volume: 9 Issue: 3
Author(s): Archana Prabahar and Jeyakumar Natarajan
Affiliation:
Keywords: microRNA, leave-one-out cross validation, major histocompatability complex, support vector machine.
Abstract: MicroRNAs (miRNAs) are short non-coding RNAs known to be involved in the gene regulatory functions in human. Major histocompatibility complex (MHC) located on the short arm of chromosome 6 remains as one of the most important regions associated with several human diseases. The complex spans ~4 Mb and covers >120 expressed genes. Gene expression at transcriptional and post transcriptional level is modulated by microRNA (miRNA) in collision with sequence polymorphism and epigenetic factors. In this study, we aim to predict miRNA responsible for different immunological functions and disorders in MHC region. Sequential and structural features of microRNAs were used for the classification of miRNA and other non-coding RNA data. Support vector machine (SVM) classifier was used for prediction and evaluated by jackknife validation technique. Overall accuracy was found to be 97.56% using leave-one-out cross validation technique. These experimental results confirm that our classification method predicts immune related miRNA with high accuracy.
Export Options
About this article
Cite this article as:
Prabahar Archana and Natarajan Jeyakumar, Prediction of miRNA in Human MHC that Encodes Different Immunological Functions Using Support Vector Machines, Current Bioinformatics 2014; 9 (3) . https://dx.doi.org/10.2174/1574893608666131120002036
DOI https://dx.doi.org/10.2174/1574893608666131120002036 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enzymatic Vitreolysis
Current Diabetes Reviews Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Hemodynamic Regulation of Metallopeptidases within the Vasculature
Protein & Peptide Letters Gastrointestinal Bleeding Associated With Warfarin and Rivaroxaban Therapy in Atrial Fibrillation Cases with Concomitant Coagulopathy
Cardiovascular & Hematological Disorders-Drug Targets SPMMTE and HPLC Methods for the Analyses of Cardiovascular Drugs in Human Plasma Using New Generation C28 Column
Current Pharmaceutical Analysis Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design Biological Therapies: Effects of Proinflammatory Pathways and their Inhibition on the Myocardium of Rheumatoid Athritis Patients
Current Medicinal Chemistry Current Trends in the Development of New Antidepressants
Current Medicinal Chemistry Hypercortisolemia and Glucocorticoid Receptor-Signaling Insufficiency in Alzheimer’ s Disease Initiation and Development
Current Alzheimer Research Genesis of Dihydropyrimidinone Calcium Channel Blockers: Recent Progress in Structure-Activity Relationships and Other Effects
Mini-Reviews in Medicinal Chemistry Update on the Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx
Cardiovascular & Hematological Disorders-Drug Targets Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?
Current Nutrition & Food Science Molecular Mechanisms of Mineralocorticoid Receptor Antagonism by Eplerenone
Mini-Reviews in Medicinal Chemistry Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study
Current Vascular Pharmacology Serotonin Reuptake Inhibitors and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Insulin Resistance in Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome
Current Pharmacogenomics Evidence of Lifestyle Modification in the Management of Hypercholesterolemia
Current Cardiology Reviews Increased Neutrophil-to-lymphocyte Ratios are Associated with Greater Risk of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
Current Diabetes Reviews